Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |